Literature DB >> 29365196

Effect of Antenatal Steroids on Respiratory Morbidity of Late Preterm Newborns: A Randomized Controlled Trial.

Vijaya Ontela1, Gowri Dorairajan1, Vishnu B Bhat2, Palanivel Chinnakali3.   

Abstract

OBJECTIVE: The objective of this article was to study the effect of antenatal dexamethasone on the respiratory morbidity of late preterm newborns. STUDY
DESIGN: A randomized controlled trial, conducted in Obstetrics and Gynecology Department in collaboration with Neonatology department at JIPMER, India. In total, 155 women were studied in each group. Intention to treat analysis and per protocol analysis were done.
RESULTS: Overall 31 (10%) newborns were admitted to intensive care unit. The composite respiratory morbidity (defined as respiratory distress syndrome and/or transient tachypnea of newborn) was observed in 64 (41.6%) infants in the study and 56 (36.2%) infants in the control group. On multivariable-adjusted analysis, use of steroids was not found to be associated with decrease in composite respiratory morbidity [adjusted relative risk 0.91 (95% confidence interval: 0.7-1.2)].
CONCLUSIONS: Antenatal dexamethasone does not reduce the composite respiratory morbidity of babies born vaginally or by emergency cesarean to women with late preterm labor.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29365196     DOI: 10.1093/tropej/fmy001

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  6 in total

Review 1.  Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.

Authors:  Alexandros Sotiriadis; Emma McGoldrick; George Makrydimas; Stefania Papatheodorou; John Pa Ioannidis; Fiona Stewart; Roses Parker
Journal:  Cochrane Database Syst Rev       Date:  2021-12-22

2.  An evaluation of the benefits and harms of antenatal corticosteroid treatment for women at risk of imminent preterm birth or prior to elective Caesarean-section: Study protocol for an individual participant data meta-analysis.

Authors:  Elizabeth Wastnedge; Joshua Vogel; Jasper V Been; Cynthia Bannerman-Gyamfi; Ewoud Schuit; Devender Roberts; Rebecca M Reynolds; Sarah Stock
Journal:  Wellcome Open Res       Date:  2020-02-25

3.  Antenatal corticosteroids for impending late preterm (34-36+6 weeks) deliveries-A systematic review and meta-analysis of RCTs.

Authors:  Mangesh Deshmukh; Sanjay Patole
Journal:  PLoS One       Date:  2021-03-22       Impact factor: 3.240

4.  The effects of betamethasone on clinical outcome of the late preterm neonates born between 34 and 36 weeks of gestation.

Authors:  Yas Arimi; Narges Zamani; Mamak Shariat; Hossein Dalili
Journal:  BMC Pregnancy Childbirth       Date:  2021-11-16       Impact factor: 3.007

Review 5.  The Use of Antenatal Dexamethasone in Late Preterm and Term Pregnancies to Improve Neonatal Morbidity and Mortality: A Systematic Review and Meta-Analysis.

Authors:  Alexandros Samouilidis; Eleftherios T Beltsios; Georgios Mavrovounis; Antonis Adamou; Ioannis Belios; Alexandros Hadjivasilis; Ioannis Pantazopoulos; Aris P Agouridis
Journal:  Cureus       Date:  2022-08-10

6.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Emma McGoldrick; Fiona Stewart; Roses Parker; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2020-12-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.